Blog
RSS FeedPosted by Michael Wonder on 22 Oct 2022
US Government is talking to companies about drug price negotiations
21 October 2022 - The US Government is holding talks with health insurers and drug makers as it sets up ...
Posted by Michael Wonder on 20 Oct 2022
New Zealand, it's time to put Fairness in Focus
20 October 2022 - Medicines New Zealand is today relaunching their digital public awareness platform Fairness in Focus. ...
Posted by Michael Wonder on 29 Sep 2022
Europe's generic drugmakers say they may cut output due to energy bills
28 September 2022 - Europe's drugmakers have warned they may stop making some cheap generic medicines because of surging electricity ...
Posted by Michael Wonder on 21 Sep 2022
The Inflation Reduction Act aims to lower drug costs — but here’s how big pharma could get around it
21 September 2022 - The tactics may ultimately threaten the law’s ability to lower drug costs for many in the US. ...
Posted by Michael Wonder on 15 Sep 2022
FDA’s drug industry fees fuel concerns over influence
15 September 2022 - The pharmaceutical industry finances about 75% of the agency’s drug division, through a controversial program that ...
Posted by Michael Wonder on 29 Aug 2022
FDA boldly bows to big pharma at Americans’ expense
29 August 2022 - A Wall Street Journal headline went this way: “Latest Covid Boosters Are Set to Roll Out ...
Posted by Michael Wonder on 23 Aug 2022
AstraZeneca's Soriot warns new US drug price law will hurt innovation
23 August 2022 - AstraZeneca's Chief Executive Pascal Soriot warned on Tuesday new US legislation capping drug prices would reduce ...
Posted by Michael Wonder on 22 Aug 2022
Drug pricing reforms can hurt innovation. Here are 3 ways to prevent that.
22 August 2022 - Giving billions of dollars in government prize money to drug companies might sound like an idea from ...
Posted by Michael Wonder on 12 Aug 2022
US move to negotiate drug prices a rare defeat for big pharma
12 August 2022 - Big pharma spent more than any other industry to lobby Congress and federal agencies this year, ...
Posted by Michael Wonder on 08 Aug 2022
PhRMA’s Ubl calls Senate passage of partisan drug pricing plan a “tragic loss for patients”
7 August 2022 - PhRMA President and CEO Stephen J. Ubl released the following statement after the U.S. Senate passed ...
Posted by Michael Wonder on 02 Aug 2022
Critics decry drug pricing provisions in Inflation Reduction Act, say they will stifle innovation
2 August 2022 - The push back against the prescription drug pricing provisions in the Inflation Reduction Act is relentless and ...
Posted by Michael Wonder on 02 Aug 2022
FDA official: patients play an increasing role in rare disease drug development
1 August 2022 - Patients have a critical role in drug development, from identifying unmet medical needs to assessing meaningful ...
Posted by Michael Wonder on 26 Jul 2022
Despite their anger over high drug prices, Americans are giving pharma credit for helping contain COVID-19
26 July 2022 - Nearly three quarters of Americans give the pharmaceutical industry credit for helping contain COVID-19 — and for ...
Posted by Michael Wonder on 30 Jun 2022
New strategic agreements with the medicines industry – PBS website updates
1 July 2022 - Amendments made by the National Health Amendment (Enhancing the Pharmaceutical Benefits Scheme) Act 2021 give effect to ...
Posted by Michael Wonder on 29 Jun 2022
Breaking the rule of drug pricing In America
29 June 2022 - Having worked in healthcare most of my life, very little surprises me. But four years ago, ...